GlassScriptPhysician profile
Joy Lynn Jones
NPI 1912638024
$2,086.38
in general payments reported to CMS, 2019-2025
24 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.04 · 2023: $1,093 · 2024: $584 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741 · Travel and Lodging: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.72 |
| Travel and Lodging | $309.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $880.84 | 2023-2024 | Axonics |
| Sumitomo Pharma America, INC. | $352.01 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $157.94 | 2022-2025 | Ams 700, Axonics, Lithovue |
| 180 Medical, INC. | $82.83 | 2023-2025 | Gentlecath Glide |
| Endo USA, INC. | $70.44 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $60.31 | 2023-2024 | Urolift |
| Coloplast Corp | $51.19 | 2024-2025 | |
| Procept Biorobotics Corporation | $48.41 | 2023 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $39.45 | 2024 | |
| Ferring Pharmaceuticals INC. | $39.41 | 2024 | Adstiladrin |
| Janssen Biotech, INC. | $32.79 | 2025 | Erleada |
| Olympus America INC. | $32.20 | 2024 | Itind System |
| Dentsply Ih Ab | $28.98 | 2023 | Lofric |
| Tolmar, INC. | $26.94 | 2025 | Eligard, Jatenzo |
| Novartis Pharmaceuticals Corporation | $25.54 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $20.56 | 2024 | Perclot |
| Urovant Sciences INC | $20.28 | 2022 | |
| Calyxo, INC. | $19.74 | 2024 | Cvac Aspiration System |
| Abbvie INC. | $19.11 | 2024 | |
| Sagent Pharmaceuticals | $18.34 | 2024 | Glydo |
| Urogen Pharma, INC. | $16.90 | 2023 | Jelmyto |
| Ambu INC. | $14.79 | 2024 | |
| Photocure INC | $14.23 | 2024 | Cysview |
| Laborie Medical Technologies Corp. | $13.15 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.